Company news
Black Diamond Therapeutics, Inc. news in 2021
Black Diamond Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
November 7, 2021
Black Diamond Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 7, 2021
Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535, BRAF, and FGFR Programs at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 7, 2021
Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-1535, BRAF, and FGFR Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 29, 2021
Black Diamond Therapeutics to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
September 20, 2021
Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform
September 20, 2021
Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 11, 2021
Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of Directors
August 9, 2021
Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 Alterations
May 18, 2021
Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial
May 16, 2021
Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 6, 2021
Black Diamond Therapeutics to Present Phase 1 BDTX-189 Data in Advanced Solid Tumors at American Society of Clinical Oncology
April 27, 2021
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
April 9, 2021
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
March 24, 2021
Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
March 9, 2021
Black Diamond Therapeutics Announces Pre-Clinical Data Presentations on New Programs Targeting BRAF and FGFR at ESMO TAT Virtual Congress 2021
March 1, 2021
Black Diamond Therapeutics to Present at the BMO Biopharma Spotlight Series
February 10, 2021
Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of Directors
January 19, 2021
Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare Conference
January 4, 2021
Decks in 2021
- Technical Presentation (2021)
Technical · 10 slides · 2021